Fri Aug 4 16:36:35 2006
Complete replication of hepatitis C virus in cell culture
Lindenbach BD, Evans MJ, Syder AJ, et al.
SCIENCE 309 (5734): 623-626 JUL 22 2005
and the citing papers
stopwords, and 2-character and smaller words are excluded, Word count: 639, All words count: 954
Grand TLCS: 116, Grand TGCS: 195| View: Overview | Sorted by number of publications (Pubs). |
Page 1 of 2: [ 1 2 ]
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 1 | HEPATITIS | 56 | 114 | 191
|
| 2 | VIRUS | 47 | 108 | 165
|
| 3 | REPLICATION | 12 | 83 | 95
|
| 4 | CELL | 10 | 78 | 79
|
| 5 | RNA | 9 | 1 | 2
|
| 6 | CELLS | 8 | 4 | 4
|
| 7 | HUMAN | 8 | 4 | 4
|
| 8 | ANTIVIRAL | 7 | 6 | 42
|
| 9 | INFECTIOUS | 7 | 7 | 9
|
| 10 | ENTRY | 6 | 5 | 5
|
| 11 | HCV | 6 | 2 | 3
|
| 12 | INHIBITOR | 5 | 1 | 1
|
| 13 | PROTEIN | 5 | 6 | 42
|
| 14 | VIRAL | 5 | 1 | 1
|
| 15 | ACTIVATION | 4 | 5 | 6
|
| 16 | CHARACTERIZATION | 4 | 0 | 0
|
| 17 | CULTURE | 4 | 76 | 77
|
| 18 | EXPRESSION | 4 | 0 | 1
|
| 19 | HEPATOMA | 4 | 4 | 4
|
| 20 | INTERFERON | 4 | 4 | 16
|
| 21 | NOVEL | 4 | 1 | 1
|
| 22 | PARTICLES | 4 | 0 | 0
|
| 23 | REPLICON | 4 | 1 | 1
|
| 24 | RIBAVIRIN | 4 | 4 | 18
|
| 25 | THERAPY | 4 | 0 | 0
|
| 26 | ACTIVITY | 3 | 0 | 0
|
| 27 | ANALYSIS | 3 | 1 | 4
|
| 28 | DISTINCT | 3 | 0 | 0
|
| 29 | EFFECT | 3 | 0 | 1
|
| 30 | EFFECTS | 3 | 1 | 3
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 31 | INHIBITS | 3 | 2 | 3
|
| 32 | LIVER | 3 | 0 | 0
|
| 33 | MECHANISM | 3 | 4 | 18
|
| 34 | MOLECULAR | 3 | 1 | 1
|
| 35 | NEW | 3 | 0 | 0
|
| 36 | POTENTIAL | 3 | 0 | 0
|
| 37 | PRODUCTION | 3 | 4 | 5
|
| 38 | PROTEASE | 3 | 0 | 0
|
| 39 | PROTEINS | 3 | 1 | 1
|
| 40 | THERAPEUTIC | 3 | 0 | 0
|
| 41 | VIVO | 3 | 2 | 4
|
| 42 | ACTION | 2 | 3 | 15
|
| 43 | ASSEMBLY | 2 | 1 | 2
|
| 44 | BINDING | 2 | 0 | 0
|
| 45 | BIOLOGICAL | 2 | 0 | 1
|
| 46 | CLEAVAGE | 2 | 0 | 0
|
| 47 | DIFFERENT | 2 | 0 | 0
|
| 48 | DISCOVERY | 2 | 0 | 0
|
| 49 | DISORDERS | 2 | 1 | 2
|
| 50 | FUNCTION | 2 | 7 | 15
|
| 51 | FUNCTIONAL | 2 | 1 | 2
|
| 52 | FUSION | 2 | 3 | 3
|
| 53 | GENOME | 2 | 7 | 15
|
| 54 | GLYCOPROTEINS | 2 | 4 | 5
|
| 55 | HCV-LIKE | 2 | 0 | 0
|
| 56 | HEPATOCYTES | 2 | 0 | 0
|
| 57 | INDUCED | 2 | 0 | 0
|
| 58 | INFECTION | 2 | 0 | 0
|
| 59 | INHIBITION | 2 | 0 | 1
|
| 60 | INHIBITORS | 2 | 0 | 0
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 61 | INNATE | 2 | 0 | 2
|
| 62 | INTERACTION | 2 | 0 | 0
|
| 63 | INTERACTIONS | 2 | 3 | 9
|
| 64 | LIPOPROTEIN | 2 | 1 | 1
|
| 65 | LIPOPROTEINS | 2 | 0 | 0
|
| 66 | LUCIFERASE | 2 | 0 | 0
|
| 67 | MECHANISMS | 2 | 0 | 0
|
| 68 | MEDIATE | 2 | 3 | 3
|
| 69 | PEPTIDE | 2 | 0 | 0
|
| 70 | POLYMERASE | 2 | 1 | 1
|
| 71 | POTENT | 2 | 0 | 0
|
| 72 | QUANTITATIVE | 2 | 1 | 4
|
| 73 | RECEPTOR | 2 | 0 | 0
|
| 74 | RECEPTORS | 2 | 0 | 0
|
| 75 | RECOMBINANT | 2 | 1 | 2
|
| 76 | REPORTER | 2 | 0 | 0
|
| 77 | RESPONSES | 2 | 0 | 0
|
| 78 | SCAVENGER | 2 | 0 | 0
|
| 79 | SCH | 2 | 0 | 0
|
| 80 | SIGNAL | 2 | 0 | 0
|
| 81 | STRAIN | 2 | 1 | 1
|
| 82 | SUBGENOMIC | 2 | 0 | 0
|
| 83 | SYSTEM | 2 | 2 | 2
|
| 84 | TARGETS | 2 | 1 | 1
|
| 85 | USING | 2 | 0 | 0
|
| 86 | VIRUS-LIKE | 2 | 0 | 0
|
| 87 | VIRUSES | 2 | 0 | 0
|
| 88 | VITRO | 2 | 2 | 2
|
| 89 | ABUSE | 1 | 0 | 0
|
| 90 | ACHILLES | 1 | 0 | 0
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 91 | ACRIDONES | 1 | 0 | 0
|
| 92 | ACTIVITIES | 1 | 0 | 0
|
| 93 | ADAPTIVE | 1 | 0 | 0
|
| 94 | ADAPTOR | 1 | 6 | 41
|
| 95 | ADVANCES | 1 | 0 | 1
|
| 96 | AGENTS | 1 | 0 | 0
|
| 97 | ALPHA | 1 | 0 | 0
|
| 98 | ALPHA-GLUCOSIDASE | 1 | 0 | 0
|
| 99 | ANALYSES | 1 | 0 | 0
|
| 100 | ANTI-BVDV | 1 | 0 | 0
|
| 101 | ANTI-HCV | 1 | 0 | 0
|
| 102 | ANTI-HEPATITIS | 1 | 1 | 1
|
| 103 | ANTIBODIES | 1 | 0 | 0
|
| 104 | ANTIBODY | 1 | 0 | 0
|
| 105 | APOB-CONTAINING | 1 | 0 | 0
|
| 106 | APOLIPOPROTEIN | 1 | 0 | 0
|
| 107 | APOPTOSIS | 1 | 1 | 2
|
| 108 | APPROACH | 1 | 0 | 0
|
| 109 | APPROACHES | 1 | 0 | 0
|
| 110 | ASSAY | 1 | 0 | 0
|
| 111 | BACULOVIRUS | 1 | 0 | 0
|
| 112 | BILIARY | 1 | 0 | 0
|
| 113 | BROADLY | 1 | 0 | 0
|
| 114 | CAPTURING | 1 | 0 | 0
|
| 115 | CARCINOMA | 1 | 0 | 0
|
| 116 | CARDIF | 1 | 6 | 41
|
| 117 | CDNA-TRANSFECTED | 1 | 2 | 2
|
| 118 | CELL-CELL | 1 | 0 | 0
|
| 119 | CHIMERAS | 1 | 0 | 0
|
| 120 | CHRONIC | 1 | 0 | 0
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 121 | CIRCLE | 1 | 1 | 2
|
| 122 | CLA | 1 | 0 | 0
|
| 123 | CLATHRIN-MEDIATED | 1 | 0 | 0
|
| 124 | CLINICAL | 1 | 0 | 1
|
| 125 | COMBINATION | 1 | 0 | 0
|
| 126 | COMPLETE | 1 | 74 | 74
|
| 127 | COMPLEX | 1 | 1 | 4
|
| 128 | CONCOMITANT | 1 | 1 | 2
|
| 129 | CONFLUENCE-BASED | 1 | 0 | 1
|
| 130 | CONSTRUCTION | 1 | 0 | 0
|
| 131 | CORE | 1 | 0 | 0
|
| 132 | CORE-RNA | 1 | 0 | 0
|
| 133 | COUNTERS | 1 | 0 | 2
|
| 134 | CULTURE-GROWN | 1 | 2 | 2
|
| 135 | CULTURED | 1 | 1 | 1
|
| 136 | CULTURES | 1 | 0 | 0
|
| 137 | CYCLOSPORIN | 1 | 0 | 0
|
| 138 | CYCLOSPORINE | 1 | 0 | 0
|
| 139 | CYTOSKELETON | 1 | 0 | 0
|
| 140 | DC-SIGN | 1 | 0 | 0
|
| 141 | DC-SIGNR | 1 | 0 | 0
|
| 142 | DEBIO | 1 | 0 | 0
|
| 143 | DEFINED | 1 | 0 | 0
|
| 144 | DELETION | 1 | 0 | 0
|
| 145 | DENSITY | 1 | 0 | 0
|
| 146 | DEPENDS | 1 | 0 | 0
|
| 147 | DETECTION | 1 | 1 | 1
|
| 148 | DEVELOPMENT | 1 | 0 | 1
|
| 149 | DIHYDROXY-4-CARBOXYPYRIMIDINES | 1 | 0 | 0
|
| 150 | DIMERIZATION | 1 | 0 | 0
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 151 | DIRECT | 1 | 0 | 0
|
| 152 | DISPENSABLE | 1 | 0 | 0
|
| 153 | DIVERSE | 1 | 0 | 0
|
| 154 | DOMAINS | 1 | 0 | 0
|
| 155 | DRUG | 1 | 0 | 1
|
| 156 | DSRNA-INDUCED | 1 | 0 | 0
|
| 157 | EARLY | 1 | 0 | 0
|
| 158 | EFFICIENTLY | 1 | 1 | 1
|
| 159 | EMPIRICISM | 1 | 0 | 0
|
| 160 | ENDOCYTOSIS | 1 | 0 | 0
|
| 161 | ENDOTHELIAL | 1 | 0 | 0
|
| 162 | ENDOTHELIUM | 1 | 0 | 0
|
| 163 | ENGAGEMENT | 1 | 0 | 0
|
| 164 | ENHANCES | 1 | 0 | 0
|
| 165 | ENVELOPE | 1 | 0 | 0
|
| 166 | EPITOPE | 1 | 0 | 0
|
| 167 | ERADICATION | 1 | 0 | 0
|
| 168 | ESCAPE | 1 | 0 | 0
|
| 169 | EXHIBITS | 1 | 0 | 0
|
| 170 | FACE | 1 | 0 | 1
|
| 171 | FEATURES | 1 | 1 | 1
|
| 172 | FULL | 1 | 1 | 2
|
| 173 | FULLY | 1 | 0 | 0
|
| 174 | FUNCTIONS | 1 | 0 | 0
|
| 175 | FUTURE | 1 | 0 | 1
|
| 176 | GENERATED | 1 | 0 | 0
|
| 177 | GENERATION | 1 | 0 | 0
|
| 178 | GENOTYPE | 1 | 1 | 1
|
| 179 | GROW | 1 | 0 | 0
|
| 180 | GROWTH | 1 | 0 | 1
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 181 | HAIRPIN | 1 | 0 | 0
|
| 182 | HEEL | 1 | 0 | 0
|
| 183 | HELICASES | 1 | 0 | 0
|
| 184 | HEPATOCELLULAR | 1 | 0 | 0
|
| 185 | HIGH | 1 | 0 | 0
|
| 186 | HIGHLY | 1 | 1 | 1
|
| 187 | HORSE | 1 | 0 | 0
|
| 188 | HOST | 1 | 0 | 0
|
| 189 | HUTCHINSON | 1 | 1 | 1
|
| 190 | IDENTIFY | 1 | 0 | 0
|
| 191 | IMMORTALIZED | 1 | 0 | 0
|
| 192 | IMMUNE | 1 | 0 | 0
|
| 193 | IMMUNITY | 1 | 0 | 2
|
| 194 | IMPLICATION | 1 | 0 | 0
|
| 195 | INCORPORATION | 1 | 1 | 2
|
| 196 | INDEPENDENT | 1 | 0 | 0
|
| 197 | INHIBIT | 1 | 0 | 0
|
| 198 | INSERTION | 1 | 0 | 0
|
| 199 | INSIGHTS | 1 | 0 | 0
|
| 200 | INTERFERENCE-MEDIATED | 1 | 0 | 0
|
Page 1 of 2: [ 1 2 ]